Wagram acted as the exclusive financial advisor to the Spanish company Nexus IT for the sale of the business line OPENLIS, a software and team dedicated to comprehensive management of hospital laboratories (LIS), to the German publicly listed company NEXUS/AG (XTRA:NXU). This strategic operation broadens NEXUS/AG’s eHealth offerings and enhances a solution already deployed in over 30 laboratories across Spain. As part of this acquisition, OPENLIS will benefit from the deep technical and functional knowledge of NEXUS/AG in developing products for the digitalization of hospital laboratories. With NEXUS/AG’s support, OPENLIS will be able to continue investing in technological advancements, strengthening its competitiveness in the market for advanced laboratory solutions and expanding its offering.
About OPENLIS
Based in Madrid, OPENLIS is a B2B software vendor serving both public and private laboratories in Spain. It offers a modular solution designed to comprehensively support the key areas of clinical laboratories and enhance the capacity of centers to manage a wide variety of analyses and studies on a single platform. OPENLIS covers pre-analytic, analytic, and post-analytic phases of modern laboratory testing, with a wide range of specialized modules, including Microbiology, Biochemistry, Hematology, Immunology and Genetics.
Wagram Corporate Finance
Advised in the sale of
Openlis (part of Nexus IT and Vortal/Hubexo Group)
to